Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZN3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,484
Award facts
- Contract value 100% obligated
- $13,483.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards $13.5K to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc., for the supply of Enhertu 100 mg vials. The contract is funded by the Defense Logistics Agency (DLA), an arm of the Department of Defense responsible for supplying medical and other commodities to military and federal health systems. The award is a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and no set-aside designation was applied, indicating the contract was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999.9M through December 2026. That prime contract serves as a comprehensive global pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a wide range of pharmaceutical products, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. Enhertu (fam-trastuzumab deruxtecan), an oncology therapeutic, represents one of the specialized medications the contractor supplies through this vehicle to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0ZN3?
SPE2DR26F0ZN3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F0ZN3 worth?
The government has obligated $13,484 on SPE2DR26F0ZN3.
Is contract SPE2DR26F0ZN3 an order under another contract?
Yes. SPE2DR26F0ZN3 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZN3 competed?
The extent of competition for SPE2DR26F0ZN3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award